Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | VCF | |||||||
GSE264052 |
Dysregulated innate immune signaling cooperates with RUNX1 mutations to transform an MDS-like disease to AML (WES)
|
12 | Kwangmin Choi | May 29, 2024 | ||||
GSE264053 |
Dysregulated innate immune signaling cooperates with RUNX1 mutations to transform an MDS-like disease to AML
|
24 | Kwangmin Choi | May 29, 2024 | ||||
GSE208366 |
Whole genome sequencing of mouse sarcoma clones
|
10 |
|
jianhong ou | May 24, 2024 | |||
GSE208367 |
COMPASS complex inhibition targets the metastasis initiating cell in undifferentiated pleomorphic sarcoma
|
26 | jianhong ou | May 24, 2024 | ||||
GSE267886 |
Neoantigen identification for 1956 and F244 murine MCA-sarcomas
|
6 |
|
Robert D Schreiber | May 20, 2024 | |||
GSE267330 |
CRISPR Screening Uncovers a Long-Range Enhancer for ONECUT1 in Pancreatic Differentiation and Links a Diabetes Risk Variant
|
33 | Samuel Joseph Kaplan | May 14, 2024 | ||||
GSE266735 |
Proteogenomics analysis to identify acquired resistance-specific alterations in melanoma PDXs on MAPKi therapy [WES]
|
6 | Stephanie D Byrum | May 10, 2024 | ||||
GSE263567 |
Brd4::Nutm1 fusion gene initiates NUT carcinoma in vivo [WGS]
|
4 | Bin Gu | May 07, 2024 | ||||
GSE266385 |
A scalable, low cost, multi-omic interrogation and sample hashing workflow for single-cell analysis using the Seq-Well S3 platform
|
9 | Daniela Dolores Russo | May 02, 2024 | ||||
GSE266289 |
Mutational analysis of TLK1 and MDM1
|
4 | Uma T Shankavaram | Apr 30, 2024 | ||||
GSE216716 |
Cancer cell genetics shaping of the tumor microenvironment reveals myeloid cell-centric exploitable vulnerabilities in hepatocellular carcinoma [WES]
|
6 | Masami Ando-Kuri | Apr 27, 2024 | ||||
GSE246610 |
Conditionally Replicative Adenovirus as a Therapy for Malignant Peripheral Nerve Sheath Tumors
|
51 |
|
David Largaespada | Apr 24, 2024 | |||
GSE234173 |
Long-term multi-modal recording reveals unpredictable nongenetic adaptation routes in dormant breast cancer cells. [WGS]
|
117 | Heena Dhiman | Apr 16, 2024 | ||||
GSE255233 |
RNA-Seq, WGS, WXS of mouse myeloma tumors derived from Vk*MYC transgenic mice
|
195 |
|
Peter Leif Bergsagel | Apr 04, 2024 | |||
GSE223772 |
Linking CRISPR/Cas9 double-strand break profiles to gene editing precision with BreakTag
|
220 | Sergi Sayols | Apr 03, 2024 | ||||
GSE248133 |
Linking CRISPR/Cas9 double-strand break profiles to gene editing precision with BreakTag [ampliseq 1]
|
12 | Sergi Sayols | Apr 03, 2024 | ||||
GSE229212 |
Development of a ß-Globin Gene Replacement Strategy as a Therapeutic Approach for ß-Hemoglobinopathies
|
69 | Kristen Seim | Apr 01, 2024 | ||||
GSE261391 |
CRISPR Screening Uncovers a Long-Range Enhancer for ONECUT1 in Pancreatic Differentiation and Links a Diabetes Risk Variant [long_read_seq]
|
1 | Samuel Joseph Kaplan | Mar 29, 2024 | ||||
GSE223005 |
Mutational analysis of PC9 and PC9-OR cell lines. [JXQ_WES]
|
4 | Jian Zhang | Mar 13, 2024 | ||||
GSE223007 |
Mutational analysis of HCC827 and HCC827-OR cell lines [HCC827OR_WES]
|
4 | Jian Zhang | Mar 13, 2024 |